Literature DB >> 18545062

The Nisonger Child Behavior Rating Form: typical IQ version.

Michael Aman1, Sarah Leone, Luc Lecavalier, Linda Park, Brett Buican, Daniel Coury.   

Abstract

The Nisonger Child Behavior Rating Form (NCBRF) has been used in several large studies of risperidone in children with low IQs (36-84) and disruptive behavior disorders (conduct disorder and oppositional defiant disorder). We wanted to develop a companion instrument for assessing 'typically developing' children and adolescents. In this study, we modified the NCBRF and obtained parent ratings on 485 typically developing children attending regular classes. We also obtained parent ratings on 46 children with conduct disorder and oppositional defiant disorder. Factor analyses of the ratings produced a single Positive Social subscale (10 items) and six Problem Behavior subscales (54 items): (i) Conduct Problems, (ii) Oppositional, (iii) Hyperactive, (iv) Inattentive, (v) Withdrawn/Dysphoric, and (vi) Overly Sensitive. Comparison of the school and disruptive behavior disorder groups showed large and significant differences, providing evidence of criterion validity for the Conduct Problem and Oppositional subscales, and on a Disruptive Total composite. Analysis for age and sex effects showed no main effects and no interaction of age and sex. Norms were presented. The factor structure of problem behavior tends to differ in significant ways between typically developing children and children having developmental disabilities. Like its predecessor, the NCBRF-TIQ (for typical IQ) is in the public domain and is available free to researchers and clinicians for assessment and treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18545062     DOI: 10.1097/YIC.0b013e3282f94ad0

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  19 in total

1.  Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Authors:  Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Robert L Findling; Oscar G Bukstein; Nicole V Brown; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi L Kipp; Jayne Schneider; Cristan A Farmer; Jennifer L Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Eric M Butter; Kristin A Buchan-Page; Elizabeth A Hurt; Adrienne B Austin; Sabrina N Grondhuis; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-12       Impact factor: 8.829

2.  Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.

Authors:  Justin A Barterian; L Eugene Arnold; Nicole V Brown; Cristan A Farmer; Craig Williams; Robert L Findling; David J Kolko; Oscar G Bukstein; Brooke S G Molina; Lisa Townsend; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-10-06       Impact factor: 8.829

3.  The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders.

Authors:  Robert L Findling; Lisa Townsend; Nicole V Brown; L Eugene Arnold; Kenneth D Gadow; David J Kolko; Nora K McNamara; Devin S Gary; Dana B Kaplin; Cristan A Farmer; Heidi Kipp; Craig Williams; Eric M Butter; Oscar G Bukstein; Robert Rice; Kristin Buchan-Page; Brooke S G Molina; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02       Impact factor: 2.576

4.  Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.

Authors:  Jeanette M Johnstone; Brenda M Y Leung; Priya Srikanth; Irene Hatsu; Leanna Perez; Barbara Gracious; Gabriella Tost; Michael G Aman; Kenneth D Gadow; Robert L Findling; Oscar Bukstein; L Eugene Arnold
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-02-26       Impact factor: 2.576

5.  Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.

Authors:  Robert L Findling; Vivian Kafantaris; Mani Pavuluri; Nora K McNamara; Jon McClellan; Jean A Frazier; Linmarie Sikich; Robert Kowatch; Jacqui Lingler; Jon Faber; Brieana M Rowles; Traci E Clemons; Perdita Taylor-Zapata
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

6.  Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.

Authors:  Kenneth D Gadow; Nicole V Brown; L Eugene Arnold; Kristin A Buchan-Page; Oscar G Bukstein; Eric Butter; Cristan A Farmer; Robert L Findling; David J Kolko; Brooke S G Molina; Robert R Rice; Jayne Schneider; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-04-13       Impact factor: 8.829

7.  Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study.

Authors:  Sabrina N Grondhuis; Cristan A Farmer; L Eugene Arnold; Kenneth D Gadow; Robert L Findling; Brooke S G Molina; David J Kolko; Kristin A Buchan-Page; Robert R Rice; Eric M Butter; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-11-15       Impact factor: 2.576

8.  Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.

Authors:  L Eugene Arnold; Kenneth D Gadow; Cristan A Farmer; Robert L Findling; Oscar Bukstein; Brooke S G Molina; Nicole V Brown; Xiaobai Li; E Victoria Rundberg-Rivera; Srihari Bangalore; Kristin Buchan-Page; Elizabeth A Hurt; Robert Rice; Nora K McNamara; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04       Impact factor: 2.576

9.  Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.

Authors:  Cristan A Farmer; Nicole V Brown; Kenneth D Gadow; L Eugene Arnold; David G Kolko; Robert L Findling; Brooke S G Molina; Kristin A Buchan-Page; Robert R Rice; Srihari S Bangalore; Oscar Bukstein; E Victoria Rundberg-Rivera; Nora McNamara; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04       Impact factor: 2.576

10.  What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?

Authors:  Michael G Aman; Oscar G Bukstein; Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi Kipp; Jayne Schneider; Eric M Butter; Jennifer Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Cristan A Farmer; Adrienne B Austin; Kristin A Buchan-Page; Nicole V Brown; Elizabeth A Hurt; Sabrina N Grondhuis; Robert L Findling
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-18       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.